Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Otology & Neurotology- |
RCV000149520 | SCV000153678 | likely pathogenic | Meniere disease | 2014-05-09 | criteria provided, single submitter | research | |
Mayo Clinic Laboratories, |
RCV001508826 | SCV001715220 | uncertain significance | not provided | 2020-03-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001508826 | SCV002005595 | likely benign | not provided | 2020-06-17 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25305078, 31589614) |
Labcorp Genetics |
RCV001849917 | SCV002293545 | uncertain significance | Left ventricular noncompaction 1 | 2024-12-05 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 715 of the DTNA protein (p.Val715Phe). This variant is present in population databases (rs533568822, gnomAD 0.01%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with DTNA-related conditions. ClinVar contains an entry for this variant (Variation ID: 140609). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |